Towards a future molecular diagnosis of autism: Recent advances in biomarkers research from saliva samples

International Journal of Developmental Neuroscience

Volumn 67, Issue , 2018, Pages 1-5

  Galiana Simal, Adrian ^a,d   Muñoz Martinez, Victoria ^b,d   Calero Bueno, Paloma ^c,d   Vela Romero, Maria ^a,d   Beato Fernandez, Luis ^b,d  

^a Clínica Pediátrica Centro de Desarrollo Infantil de Ciudad Real   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

^c UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^d Grupo de Investigación en Trastornos del Neurodesarrollo de Ciudad Real TNDCR   (Spain)

Author keywords

Autism; Biomarker; Diagnosis; miRNA; Saliva

Indexed keywords

BIOLOGICAL MARKER; HYDROCORTISONE; MICRORNA; SALIVA PROTEIN; SEX HORMONE;

AUTISM; CLINICAL EFFECTIVENESS; CORRELATIONAL STUDY; DISEASE ASSOCIATION; HUMAN; MOLECULAR DIAGNOSIS; PREDICTION; PRIORITY JOURNAL; REVIEW; SALIVA ANALYSIS; SALIVA LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; METABOLISM; MOLECULAR PATHOLOGY; PROCEDURES; SALIVA; TRENDS;

AUTISTIC DISORDER; BIOMARKERS; HUMANS; PATHOLOGY, MOLECULAR; SALIVA;

EID: 85046042080     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2018.03.004     Document Type: Review

References (45)

1. Abdulla, A.M., Hegde, A.M., Salivary cortisol levels and its implication on behavior In children with autism during dental treatment. J. Clin. Pediatr. Dent. 39 (2015), 128–132.
2. Agostinho, P., Cunha, R.A., Oliveira, C., Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr. Pharm. Des. 16 (2010), 2766–2778.
3. Anitha, A., Thanseem I microRNA and autism. Adv. Exp. Med. Biol. 888 (2015), 71–83.
4. Anon, B., SPARK. a US cohort of 50, 000 families to accelerate autism research. Neuron 97 (2018), 488–493.
5. Auyeung, B., Ahluwalia, J., Thomson, L., et al. Prenatal versus postnatal sex steroid hormone effects on autistic traits in children at 18–24 months of age. Mol. Autism, 3, 2012, 17.
6. Bakunina, N., Pariante, C.M., Zunszain, P.A., Immune mechanisms linked to depression via oxidative stress and neuroprogression. Immunology 144 (2015), 365–373.
7. Braam, W., Keijzer, H., Struijker Boudier, H., Didden, R., Smits, M., Curfs, L., CYP1A2 polymorphisms in slow melatonin metabolisers: a possible relationship with autism spectrum disorder. J. Intellect. Disabil. Res. 57 (2013), 993–1000.
8. Corbett, B.A., Mendoza, S., Abdullah, M., Wegelin, J.A., Levine, S., Cortisol circadian rhythms and response to stress in children with autism. Psychoneuroendocrinology 31 (2006), 59–68.
9. Csosz, E., Kallo, G., Markus, B., Deak, E., Csutak, A., Tozser, J., Quantitative body fluid proteomics in medicine – a focus on minimal invasiveness. J. Proteomics 153 (2017), 30–43.
10. DuBois, D., Lymer, E., Gibson, B.E., Desarkar, P., Nalder, E., Assessing sensory processing dysfunction in adults and adolescents with autism spectrum disorder: a scoping review. Brain Sci., 2017, 7.
11. Ecker, C., Autism biomarkers for more efficacious diagnosis. Biomark. Med. 5 (2011), 193–195.
12. Gallo, A., Alevizos, I., Isolation of circulating microRNA in saliva. Methods Mol. Biol. 1024 (2013), 183–190.
13. Geoffray, M.M., Nicolas, A., Speranza, M., Georgieff, N., Are circadian rhythms new pathways to understand autism spectrum disorder?. J. Physiol. Paris 110 (2016), 434–438.
14. Goldani, A.A.S., Downs, S.R., Widjaja, F., Lawton, B., Hendren, R.L., Biomarkers in autism. Front. Psychiatry, 5, 2014, 100.
15. Goode, M.R., Cheong, S.Y., Li, N., Ray, W.C., Bartlett, C.W., Collection and extraction of saliva DNA for next generation sequencing. J. Vis. Exp., 90, 2014, e51697, 10.3791/51697.
16. Harris, J.C., New classification for neurodevelopmental disorders in DSM-5. Curr. Opin. Psychiatry 27 (2014), 95–97.
17. Hassaneen, M., Maron, J.L., Salivary diagnostics in pediatrics: applicability, translatability, and limitations. Front. Public Health, 5, 2017, 83.
18. Hicks, S.D., Middleton, F.A., A comparative review of microRNA expression patterns in autism spectrum disorder. Front. Psychiatry, 7, 2016, 176.
19. Hicks, S.D., Ignacio, C., Gentile, K., Middleton, F.A., Salivary miRNA profiles identify children with autism spectrum disorder, correlate with adaptive behavior, and implicate ASD candidate genes involved in neurodevelopment. BMC Pediatr., 16, 2016, 52.
20. Human, Hofman L.F., Saliva as a diagnostic specimen. J. Nutr. 131 (2001), 1621S–1625S.
21. Joseph, N., Zhang-James, Y., Perl, A., Faraone, S.V., Oxidative stress and ADHD: a meta-analysis. J. Atten. Disord. 19 (2015), 915–924.
22. Kern, J.K., Geier, D.A., Sykes, L.K., Geier, M.R., Relevance of neuroinflammation and encephalitis in autism. Front. Cell. Neurosci., 9, 2015, 519.
23. Koni, A.C., Scott, R.A., Wang, G., et al. DNA yield and quality of saliva samples and suitability for large-scale epidemiological studies in children. Int. J. Obes. (Lond.) 35:Suppl. 1 (2011), S113–8.
24. Majewska, M.D., Hill, M., Urbanowicz, E., et al. Marked elevation of adrenal steroids, especially androgens, in saliva of prepubertal autistic children. Eur. Child Adolesc. Psychiatry 23 (2014), 485–498.
25. McGinnis, W.R., Oxidative stress in autism. Altern. Ther. Health Med. 10 (2004), 22–36 quiz 37, 92.
26. Ngounou, Wetie A.G., Wormwood, K.L., Russell, S., Ryan, J.P., Darie, C.C., Woods, A.G., A pilot proteomic analysis of salivary biomarkers in autism spectrum disorder. Autism Res. 8 (2015), 338–350.
27. Ngounou, Wetie A.G., Wormwood, K.L., Charette, L., Ryan, J.P., Woods, A.G., Darie, C.C., Comparative two-dimensional polyacrylamide gel electrophoresis of the salivary proteome of children with autism spectrum disorder. J. Cell. Mol. Med. 19 (2015), 2664–2678.
28. Ogawa, S., Lee, Y.A., Yamaguchi, Y., Shibata, Y., Goto, Y., Associations of acute and chronic stress hormones with cognitive functions in autism spectrum disorder. Neuroscience 343 (2017), 229–239.
29. Rani, V., Deep, G., Singh, R.K., Palle, K., Yadav, U.C., Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies. Life Sci. 148 (2016), 183–193.
30. Ratajczak, H.V., Sothern, R.B., Measurement in saliva from neurotypical adults of biomarkers pertinent to autism spectrum disorders. Future Sci. OA, 1, 2015, FSO70.
31. Sappok, T., Heinrich, M., Underwood, L., Screening Tools for Autism Spectrum Disorders. 2015.
32. Scott, O., Shi, D., Andriashek, D., Clark, B., Goez, H.R., Clinical clues for autoimmunity and neuroinflammation in patients with autistic regression. Dev. Med. Child Neurol. 59 (2017), 947–951.
33. Sharpley, C.F., Bitsika, V., Andronicos, N.M., Agnew, L.L., Is afternoon cortisol more reliable than waking cortisol in association studies of children with an ASD?. Physiol. Behav. 155 (2016), 218–223.
34. Sinclair, D., Purves-Tyson, T.D., Allen, K.M., Weickert, C.S., Impacts of stress and sex hormones on dopamine neurotransmission in the adolescent brain. Psychopharmacology (Berl) 231 (2014), 1581–1599.
35. Tamiji, J., Crawford, D.A., The neurobiology of lipid metabolism in autism spectrum disorders. Neurosignals 18 (2010), 98–112.
36. Theoharides, T.C., Asadi, S., Patel, A.B., Focal brain inflammation and autism. J. Neuroinflammation, 10, 2013, 815.
37. Tordjman, S., Anderson, G.M., Kermarrec, S., et al. Altered circadian patterns of salivary cortisol in low-functioning children and adolescents with autism. Psychoneuroendocrinology 50 (2014), 227–245.
38. Torrico, B., Chiocchetti, A.G., Bacchelli, E., et al. Lack of replication of previous autism spectrum disorder GWAS hits in European populations. Autism Res 10 (2017), 202–211.
39. Upadhyay, R.K., Emerging risk biomarkers in cardiovascular diseases and disorders. J. Lipids, 2015, 2015, 971453.
40. Vorstman, J.A.S., Parr, J.R., Moreno-De-Luca, D., Anney, R.J.L., Nurnberger, J.I. Jr., Hallmayer, J.F., Autism genetics: opportunities and challenges for clinical translation. Nat. Rev. Genet. 18 (2017), 362–376.
41. Werling, D.M., Geschwind, D.H., Sex differences in autism spectrum disorders. Curr. Opin. Neurol. 26 (2013), 146–153.
42. Wong, D.T., Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J. Am. Dent. Assoc. 137 (2006), 313–321.
43. Wormwood, K.L., Aslebagh, R., Channaveerappa, D., et al. Salivary proteomics and biomarkers in neurology and psychiatry. Proteomics Clin. Appl. 9 (2015), 899–906.
44. Xiao, Z., Qiu, T., Ke, X., et al. Autism spectrum disorder as early neurodevelopmental disorder: evidence from the brain imaging abnormalities in 2–3 years old toddlers. J. Autism Dev. Disord. 44 (2014), 1633–1640.
45. Zendjabil, M., Favard, S., Tse, C., Abbou, O., Hainque, B., The microRNAs as biomarkers: what prospects?. C. R. Biol. 340 (2017), 114–131.